Induced pluripotent stem cells have many similar properties to embryonic stem cells and research continues to make progress; however, these cells cannot yet be produced to clinical standard or be treated as natural cells.

Some of the measures to achieve this important goal should include: a focus on the increasing enrolment of ethnic minorities and mixed minorities; a focus on the increased enrolment of younger donors, aged 18 to 35, as the youth of their stem cells can lead to better transplant outcomes, as published; the establishment of a national cord blood bank in Canada, ethnically diverse, which would be a complementary and long-awaited stem cell source for many patients who cannot find an unrelated donor match; increased funding for research in the area of mismatched donor transplantation, to establish whether manipulation, a graft, and/or the recipient's immune system can lead ...[+++]to improvement in clinical outcomes; continuing the present efforts and adopting new ways to increase awareness among the Canadian public about the importance of becoming a stem cell donor; and perhaps increasing funding to allow for the thorough and accurate reporting of the outcomes of stem cell transplants to the Canadian Blood and Marrow Transplant Group, the only group that collects this clinical data, which in turn might lead to improvements in transplantation outcomes.

It is not clear if the system of stem cells found in particular tissues is entirely separate, or somehow dependent on the bone marrow system.

Hodges also notes that because adult patients can donate their own stem cells for treatment, the cells are not treated as foreign objects by the body's immune system and rejected.

Because thousands of Canadians suffer from debilitating diseases and illnesses, such as Parkinson's, Alzheimer's, diabetes, cancer, multiple sclerosis and spinal cord injury; and because Canadians support ethical stem cell research which has shown encouraging results; and while non-embryonic stem cells, which are also known as adult stem cells, have shown significant research progress without the immune rejection or ethical problems, the petitioners ask Parliament to focus its legislative support on adult stem cell research to find the cures and therapies necessary to treat the illnesses and diseases of suffering Canadians.

Embryonic stem cell transplants are subject to immune rejection because they are foreign tissues while one's own adult stem cells, which are used in different therapies, are not subjected to the same rejection question.